← brief for 2026-09-01 · Slowing decline

Soluble CD163 as a Non-Invasive Biomarker in Autoimmune Nephrological and Rheumatological Diseases.

Key takeaways

A review of studies found that a blood or urine test for soluble CD163 — a sign of immune cell activity — may help track inflammation in autoimmune diseases that affect the kidneys, like lupus. Because all the studies were observational, they show a link but do not prove the test causes or predicts kidney damage. Doctors are still learning how useful this test is in practice.

Who did this work

Kamińska D · Poznański P · Tański W · Skotny A

Source

Article · PubMed, CKD severity and reversal · 2026 Sep 1
https://pubmed.ncbi.nlm.nih.gov/42678743/